Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic
Leigh Turner, Megan Munsie, Aaron D Levine, Laertis Ikonomou
STEM CELL REPORTS | CELL PRESS | Published : 2021
The significant morbidity and mortality of coronavirus disease 19 (COVID-19) prompted a global race to develop new therapies. These include interventions using cell- or cell-derived products, several of which are being tested in well-designed, properly controlled clinical trials. Yet, the search for cell-based COVID-19 treatments has also been fraught with hyperbolic claims; flouting of crucial regulatory, scientific, and ethical norms; and distorted communication of research findings. In this paper, we critically examine ethical issues and public communication challenges related to the development of cell-based therapeutics for COVID-19. Drawing on the lessons learned from this ongoing proc..View full abstract
Awarded by National Science Foundation
A.D.L.'s work on this paper was supported, in part, by the National Science Foundation under grant EEC-1648035.